目的:分析非小细胞肺癌(NSCLC)组织中DNA修复基因XerodermaPigmentosumGroupA(xPA)的表达状况及其与临床病理特征的关系。方法:采用免疫组织化学方法(IHC)检测初治中晚期NSCLC患者癌组织中XPA的表达状况,采用X^2检验比较各亚组之间的XPA表达状况的差异。结果:109例NSCLC组织中XPA的阳性表达率为55.0%(60/109),其表达与性别、吸烟史有密切关系,在男性组中的阳性率(61.0%)显著高于女性组(37.0%)(P=0.030);吸烟组的XPA阳性率显著高于不吸烟组(分别为68.1%和45.2%,P=0.017);但在吸烟人群中,吸烟量不同的亚组间XPA的表达率未见明显差异。XPA阳性率在不同年龄、临床TNM分期、组织学类型或分化程度、淋巴结转移和远处转移亚组中的差异均无统计学意义(均P〉0.05)。结论:XPA在NSCLC组织中的表达状况与性别、吸烟状况密切相关,并可能与NSCLC的发生有关。
Objective:To investigate the association between the expression of DNA repair gene XPA with the clinicopathology characteristics in patients with advanced non-small cell lung cancer (NSCLC) and its clinical significance. Methods: The expression, of XPA was examined with immunohistochemistry (IHC), the positive expression rate of XPA in different clinicopathology characteristic groups was analyzed. Re- sults: In 109 patients with NSCLC, the positive rate of XPA was 55.0% (60/109), and the expression rate in males was significantly higher than that in females (61.0% vs. 37.0%, P =0.030). The expression rate was also higher in smokers than in non-smokers (68.1% vs. 45.2%, P=0. 017). There were no sig- nificant differences in the expression of XPA among different ages, TNM stages, and pathological classifi- cation ( P 〉0.05 for all). Conclusion: In NSCLC cases, the expression status of XPA is markedly associ- ated with gender and smoking status. Thus, XPA may play a potential role in non-small cell lung cancer occur process.